| NAME |
GOLIMUMAB 50MG/0.5ML INJ SYRINGE |
| VA GENERIC NAME |
GOLIMUMAB |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Golimumab_(Simponi)_(2020).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
50 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/0.5ML |
| NATIONAL FORMULARY NAME |
GOLIMUMAB INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GOLIMUMAB 50MG/0.5ML INJ SYRINGE |
| VA PRODUCT IDENTIFIER |
G0322 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4028659 |
| EFFECTIVE DATE/TIME |
-
- 2009-06-10 00:00:00
- STATUS: ACTIVE
|
